GoHealth’s analyst fair value estimate has shifted from US$7.70 to US$4.70, bringing the price target closer to the recent reset discussed earlier. Some analysts with a more optimistic view see this new level as a cleaner entry point and a better reflection of execution risk. In contrast, more cautious analysts view the cut as a reminder that earlier forecasts may have been too optimistic. As you read on, you will see how to track this evolving narrative and what to watch for in the next...

GoHealth (GOCO) delivered earnings and revenue surprises of +61.71% and -84.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

The latest update on GoHealth keeps the fair value target steady at 7.7 with the discount rate unchanged at 12.5%, so the core valuation framework remains intact even as expectations around the business are recalibrated. Revenue growth assumptions now reflect roughly a 10.75% decline, which ties back to weaker Q3 trends and the impact of a suspended carrier relationship, while still acknowledging bullish views that tighter cash burn and more disciplined enrollment could create a cleaner base...

Recent updates to GoHealth’s price target are less about a change in the headline fair value, which stays at 7.7, and more about how analysts are thinking about the path the company might take to get there. With the discount rate still at 12.5% and revenue expectations pointing to a slightly smaller 10.75% decline, the latest narrative reflects both the weaker Q3 showing and management’s focus on cash discipline and tighter growth ambitions. As these inputs are refreshed to match new carrier...

GoHealth’s fair value estimate has been sharply lowered from $14 to $7.70 per share following the company’s latest earnings and operational performance updates. Analysts cite weaker revenue forecasts as the reason for the adjustment, reflecting both recent challenges and cautious optimism around management’s focus on stability. Stay tuned to discover how developments like these can help you track important shifts in the stock’s outlook going forward. Stay updated as the Fair Value for...

GoHealth’s fair value estimate has recently been lowered from $17.20 to $14.00. This reflects a notable shift in analyst sentiment driven by updated assumptions. The adjustment comes as analysts weigh mixed financial results, slight changes in the discount rate, and sector-wide uncertainties that continue to influence expectations for the company’s future. Stay tuned to discover how you can keep abreast of ongoing changes and insights shaping the evolving GoHealth narrative. Analyst Price...

GoHealth Inc (GOCO) focuses on retention and operational efficiency amid a dynamic Medicare Advantage landscape.

CHICAGO (AP) — GoHealth, Inc. A (GOCO) on Thursday reported a loss of $165.8 million in its third quarter. The Chicago-based company said it had a loss of $11.80 per share.

Key Insights Given the large stake in the stock by institutions, GoHealth's stock price might be vulnerable to their...